The study authors, writing in the May 9 issue of the Journal of the American Medical Association, said additional legislation is needed to increase pediatric clinical trials and improve labeling. Current legislation comes up for reauthorization this year, and the American Academy of Pediatrics is requesting that the laws regarding drug-testing in newborns be strengthened, Frattarelli said.
The U.S. Food and Drug Administration has more on the study of drugs in children.
Copyright © 2012 HealthDay. All rights reserved.